Home » Newsletters » BioWorld Science

BioWorld Science

March 4, 1997

View Archived Issues

Gull Laboratories reports year-end and fourth-quarter results

Medtronic reports quarterly earnings up 20.8%

SmithKline Beecham reports strong growth for 1996, fueled by success of new products

T Cell Sciences reports 1996 fourth-quarter and year-end financial results

Unimed reports 1996 results: Earnings exceed published estimates

RCT discloses compounds for radiolabeling leukocytes/lymphocytes

Takeda describes antitumor agents

Antiarrhythmic agents reported by National Science Council

TK inhibitors disclosed by Pfizer

Cephalosporin antibiotics revealed by Microcide

Zeneca reports cell adhesion inhibitors

Novel class of immunosuppressants disclosed by Novartis

Comparative efficacy and tolerance of s.c. and i.m. Puregon

Dorzolamide and timolol alone and in combination for glaucoma

Sustained-release methylphenidate for HIV-associated cognitive impairment

Pramlintide delays gastric emptying in IDDM

Gamma-hydroxybutyrate associated with dependence liability

First launch for troglitazone

Celgene receives patent for selective cytokine-inhibitory drugs

Faulding receives approval for etodolac tablets

Teva's Tolmetin approved

Watson and Oclassen merge

Vyrex and SeqWright collaborate to develop CD-Tagging technology

ViroPharma receives milestone payment from Boehringer Ingelheim

Roche's Roferon-A receives EU approval

Hemagen's CMV diagnostic cleared for marketing

FDA advisory committee decision regarding Integrilin

ONYX expands ONYX-015 clinical trials

ViroPharma's antiviral candidate enters pediatric clinical trials

Advisory committee to review supplemental NDA for Maxipime

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...